For example, in our study, MDR1 mRNA evaluation had a stronger prognostic value for patients with primary acute leukemia, whereas P-gp expression levels more strongly correlated with the therapy response, drug sensitivity, and prognostic markers in patients with secondary acute leukemia. The gene discussed is PGP; the disease is acute leukemia.